Amoeba : Amoéba signs an exclusive development and marketing agreement in France with PHILAGRO for its grapevine biocontrol product

PRESS RELEASE

AMOEBA SIGNS AN EXCLUSIVE DEVELOPMENT AND MARKETING AGREEMENT

IN FRANCE WITH PHILAGRO FOR ITS GRAPEVINE BIOCONTROL PRODUCT

Chassieu (France), December 9, 2020 - 5.45 pm- AMOEBA (FR0011051598 - ALMIB), producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product for plant protection, still in the testing phase, announces the signature of a Letter of Intent (LOI) with PHILAGRO France, concerning the development and marketing of its biocontrol product against vine downy mildew in France.

This signature, with a recognised player in the crop protection market, an entity born from the strategic alliance of three Japanese groups (SUMITOMO Chemical Company, NISSAN Chemical Industries and NIHON NOHYAKU Company), follows on from the partnership announced in April 2020 to evaluate the performance of the biocontrol fungicide containing AMOEBA's active substance: the amoeba lysate Willaertia magna C2c Maky.

The aim of the LOI is to define the collaboration outlines between the two companies before and after the marketing of the product on the French territory with a view to signing a commercial partnership contract within 12 months.

Amoéba will carry out the regulatory tests necessary for the registration of its product and PHILAGRO will refine the marketing and commercial positioning of the product through field trials.

Amoéba has made an exclusive commitment with PHILAGRO France concerning vine application over a marketing period of several years in France, the leading European market for downy mildew treatment.

"The Philagro team is delighted to be able to work with Amoéba for the development and future marketing of this very promising biocontrol solution in the strategic segment of the vine downy mildew. The two companies share a common vision of the evolution of the French market and high expectations in biocontrol innovations, complementing each other perfectly to make this solution a real technical and commercial success" explains Denis TROALEN, General Manager of PHILAGRO France.

"The choice of PHILAGRO as an exclusive partner is guided by more than 25 years of experience in the service of crop protection, a strong operational positioning in biocontrol and a real capacity for commercial execution in this strategic segment. The human relationship established between our two companies during this 2020 year of field tests has convinced us of the unfailing motivation of the teams to make the most of our product against vine downy mildew in France. "comments Fabrice PLASSON, Chairman and CEO of Amoéba.

Adresse : 38 Avenue des Frères Montgolfier, 69680 CHASSIEU	Tel: [phone] - Email: [e-mail]
Société Anonyme au capital de 311 578,38 €	Linkedin: @amoeba-nature - Twitter: @AmoebaNature
RCS Lyon 523 877 215	www.amoeba-nature.com

About Philagro

Philagro is the result of the strategic alliance of 3 Japanese R&D groups: SUMITOMO Chemical Company, NISSAN Chemical Industries and NIHON NOHYAKU Ltd.

Recognised player in crop protection since 1993, PHILAGRO designs, develops and markets solutions that are compatible with Sociéty's economic and environmental requirements.

About AMOEBA:

Amoéba's ambition is to become a major player in the treatment of bacterial risk in the fields of water, healthcare and plant protection. Our biological solution is an alternative to chemical products widely used today. Amoéba is currently focusing on the market of industrial cooling towers estimated at €1.7Bn (1) on a global chemical biocide market for water treatment, evaluated at €21Bn (2) and on the biocontrol market for plant protection estimated globally at €1.6Bn (4). In the future, the Company is looking at developing new applications such as chronic wound care, estimated at € 751 million (3) in the USA. Sales of associated products with healthcare, biocides and crop protection are subject to the Company being granted local regulatory market authorizations. The Company is currently in a trial phase for biocidal and plant protection applications and does not market any products.

Created in 2010, based in Chassieu (Lyon, France) with a subsidiary in Canada and in the United States, Amoéba is quoted on Euronext Growth. The Company is a member of the BPIfrance Excellence network and is eligible for the PEA-PME SME equity savings plan setup. More information on www.amoeba-biocide.com.

(1): Amoéba data combined from sources: DRIRE 2013, Eurostat, ARHIA 2013

(2): Sources combined by Amoéba from water treaters, Freedonia, Eurostat et MarketsandMarkets

(3): BCC Research, "Markets for Advanced Wound Management Technologies," Wellesley, MA, 2017

(4): Biopesticides Worldwide Market 2013, CPL, Wallingford, UK

Contacts:
Amoéba	Calyptus
Valérie FILIATRE	Relations investisseurs & Presse
Directeur Général Adjoint	Grégory BOSSON / Mathieu CALLEUX
[phone]	[phone] /91
[e-mail]	[e-mail]

Disclaimer

This press release contains certain forward-looking statements concerning AMOEBA which are based on its own assumptions and hypothesis and on information that are available to us. However, AMOEBA gives no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the Universal Registration Document of AMOEBA filed with the French Financial Markets Authority (Autorité des Marchés Financiers) on April 30, 2020 under number D20-0416 (a copy of which is available on www.amoeba-biocide.com). The forward-looking statements contained in this press release are also subject to risks not yet known to AMOEBA or not currently considered material by AMOEBA. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of AMOEBA to be materially different from such forward-looking statements.

Adresse : 38 Avenue des Frères Montgolfier, 69680 CHASSIEU	Tel: [phone] - Email: [e-mail]
Société Anonyme au capital de 311 578,38 €	Linkedin: @amoeba-nature - Twitter: @AmoebaNature
RCS Lyon 523 877 215	www.amoeba-nature.com